Ficonalkib

DB18774InvestigationalSmall molecule

Ficonalkib: Overview.

Mechanism: Pharmacologically active on ALK tyrosine kinase receptor and Leukocyte tyrosine kinase receptor
Curator reviewed
Formula / weight: C₂₉H₃₉N₇O₃S · 565.74 g/mol (avg)
Code names: SY-3505

Resolves to

Compound

Structure

InChIKeyLDTJJGGYLQQRSP-UHFFFAOYSA-NSMILESCOC1=CC(=CC=C1NC1=NC2=C(CCN2)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)N1CCC(CC1)N(C)C

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ficonalkib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.